Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Office Of The Ohio Attorney General currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is being handled by 1 distinct examiner and 1 distinct art unit. This indicates a highly focused prosecution effort, likely centered on a single technical filing.
SARAE L BAUSCH is the busiest examiner for this portfolio, with 1 busiest examiner pending action currently assigned to her. As the only examiner involved, her individual review of the Biotechnology & Pharmaceuticals claims will determine the outcome of the case. The involvement of 1 distinct art unit further reinforces the concentrated nature of this active prosecution.
The legal team's current workload is limited to 1 pending office action, allowing for a deep focus on the specific issues raised by the examiner. There is no distribution of cases across other units or officials. This active matter represents the current extent of the entity's active engagement with the patent examination process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAUSCH, SARAE L | 1 | 29.7% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18672523 | Genetic Variants Associated with Opioid Use Disorder | BAUSCH, SARAE L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18672523 | Genetic Variants Associated with Opioid Use Disorder | BAUSCH, SARAE L | — |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18672523 | Genetic Variants Associated with Opioid Use Disorder | BAUSCH, SARAE L | 1699 | §101§102§103 | Non-Final OA | — | Pending | May 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOffice Of The Ohio Attorney General has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sarae L Bausch has the most, with 1 of Office Of The Ohio Attorney General's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
